Abstract:OBJECTIVE:The application of dexmedetomidine in patient sedation is generally accepted, though its clinical application is limited because of the lack of information detailing the specific properties among diverse populations of patients. The aim of this study was to compare the pharmacokinetic and pharmacodynamic characteristics of dexmedetomidine between elderly and young patients during spinal anesthesia.METHODS:34 subjects (elderly group: n = 15; young group: n = 19) with spinal anesthesia were enrolled in the present study following the inclusion/exclusion criteria detailed below. All subjects received intravenous infusion of dexmedetomidine with a loading dose of 0.5 µg x kg⁻¹ for 10 minutes and a maintenance dose of 0.5 µg x kg⁻¹ x h⁻¹ for 50 minutes. Plasma concentrations of dexmedetomidine were detected by the HPLC-MS/MS method and pharmacokinetic parameters were calculated using WinNolin software.RESULTS:There was no significant difference between the elderly and young subjects in major pharmacokinetic parameters. There was a marked gender difference in the Cmax (peak plasma concentration) and tmax (time to reach Cmax) between genders in elderly subjects, though in this cohort the other pharmacokinetic parameters were not significantly different. In the young subjects there were no noteworthy variations between genders in pharmacokinetic parameters. There was no significant difference between the two groups in BISAUC(0-t) (the area under the bispectral index-time curve from time 0 to t hours), BISmin (the minimum value of the bispectral index after drug delivery), and or tmin-BIS (bispectral index for the minimum value of time). SBP (systolic blood pressure), DBP (diastolic blood pressure), HR (heart rate), and SpO₂(pulse oxygen saturation) developed substantive differences in a time-dependent manner, but there were no statistically significant differences in these four indicators in the time*group at three time points (1 hour, 2 hours, and 3 hours after drug administration); while SBP was significantly different between the groups, this differential declined in a time-dependent manner, and there were no significant attendant differences in the D-value. The observed values and D-values of DBP and HR were similar in the groups, but the observed value and D-value of SpO₂did differ. There were 14 drug-related adverse events in the young group, and 26 drug-related adverse events in the elderly group, a 46% differential. The percentage of patients who requiring intervention during surgery was 68.75% (11/16) in the elderly group and 36.84% (7/19) in the young group, with no significant difference between the two groups once age was factored in (p = 0.06). None of the pharmacodynamic indices, however, correlated with the key pharmacokinetic parameters (Cmax, AUC(0→t), AUC(0→∞)) of dexmedetomidine.CONCLUSIONS:The clearance of dexmedetomidine in elderly patients showed a declining trend compared to young patients. Interventions in the elderly group were more frequent than in the young group, and the elderly group showed significant adverse effects. It is suggested that elderly patients who use dexmedetomidine may benefit from a different dose. However, further research with a larger population size is required to confirm these findings.

Sedative effect of different speed of intravenous infusion of dexmedetomidine detected by Narocotrend index on elderly patients

Pharmacokinetic and Pharmacodynamic Study of Dexmedetomidine in Elderly Patients During Spinal Anesthesia

Effects of dexmedetomidine on hemodynamics in the elderly patients

Effects of Age Factors on Sedation Induced by Dexmedetomidine

Clinical trial of dexmedetomidine in anesthesia of elderly patients with hip fracture

[Sedative Effects of Dexmedetomidine in Post-Operative Elder Patients on Mechanical Ventilation].

Effect of dexmedetomidine on convalescence quality after general anesthesia and postoperative delirium, and on cognitive function in elderly patients undergoing lower limb surgery

Dexmedetomidine for Sedation During Low Epidural Anesthesia in 22 Elderly Patients

Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: a randomized controlled trial

The effect of dexmedetomidine on the incidence of postoperative delirium in critically ill elderly patients

Effects Of Dexmedetomidine Combined With Remifentanil On The Hemodynamics In Elderly Patients Undergoing Abdominal Surgery Under Total Intravenous Anesthesia

Application of dexmedetomidine in the aged patients with total hip replacement surgery

Effects of Dexmedetomidine During Combined Intravenous-Inhalational Anesthesia on Motor Evoked Potentials Monitoring and Postoperative Agitation in Elderly Patients Undergoing Cervical Spine Sur-Gery

Effects of preanesthetic dexmedetomidine on hemodynamic responses to endotracheal intubation in elderly patients undergoing treatment for hypertension: a randomized, double-blinded trial

Clinical Effect of Dexmedetomidine Combined with Dezocine in Elderly Patients with Upper Abdominal Operation During Recovery from General Anesthesia

Dexmedetomidine-induced anesthesia in elderly patients undergoing hip replacement surgery

[Effects of Dexmedetomidine on Perioperative Cardiac Adverse Events in Elderly Patients with Coronary Heart Disease].

Sedative effect of dexmedetomidine in patients undergoing knee arthroplasty under sciatic nerve combined with femoral nerve block anesthesia

Effects of Single-dose Intravenous Dexmedetomidine on Combined Spinal Epidural Anesthesia: a Prospective Randomized Controlled Trial

Effects of different dose of dexmedetomidine on postoperative deliriumin from general anaesthesia undergoing hip-replacement surgery in aged hypertensive patients

Influence of Dexmedetomidine on Sedation